A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis.
Peng PengShu SuChristopher K FairleyMinjie ChuShengyang JiangXun ZhuangLei ZhangPublished in: AIDS and behavior (2019)
Pre-exposure prophylaxis (PrEP) is a new biomedical intervention for HIV prevention. This study systematically reviews the acceptability of PrEP among men who have sex with men (MSM) worldwide. We searched major English databases to identify English-language articles published between July 2007 and July 2016, which reported the acceptability of PrEP and associated population characteristics. Meta-analysis was conducted to estimate a pooled acceptability, and meta-regression and subgroup analysis were used to analyse heterogeneities. The estimated acceptance from included sixty-eight articles was 57.8% (95% confidence internal 52.4-63.1%). MSM who were younger (4/5 studies, range of adjusted odds ratio (aOR) = 1.39-3.47), better educated (aOR = 1.49-7.70), wealthier (aOR = 1.31-13.03) and previously aware of PrEP (aOR = 1.33-3.30) showed significantly higher acceptance. Male sex workers (84.0% [26.3-98.7%] were more likely to accept PrEP than general MSM. Self-perceived low efficacy, concern about side effects, adherence, affordability, and stigma were main barriers. This review identifies a moderate acceptability of PrEP in MSM. Efficacy, perception of HIV risk and experienced stigma determine its acceptance.
Keyphrases
- men who have sex with men
- hiv testing
- hiv positive
- mental health
- social support
- systematic review
- hiv aids
- randomized controlled trial
- meta analyses
- case control
- autism spectrum disorder
- mental illness
- hiv infected
- depressive symptoms
- genome wide
- clinical trial
- physical activity
- metabolic syndrome
- type diabetes
- big data
- adipose tissue
- insulin resistance
- glycemic control